Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 09

28P - Xanthine oxidase as a prognostic factor in colorectal cancer metastatic disease

Date

21 Oct 2023

Session

Poster session 09

Topics

Basic Science

Tumour Site

Colon and Rectal Cancer

Presenters

Anton Burlaka

Citation

Annals of Oncology (2023) 34 (suppl_2): S187-S214. 10.1016/S0923-7534(23)01931-2

Authors

A.A. Burlaka1, A. Burlaka2, V. Rozhkova1, S.V. Zemskov3, I.I. Lisnyy4

Author affiliations

  • 1 Department Of Minimally Invasive And Endoscopic Surgery, Interventional Radiology, National Cancer Institute of the Ministry of Health of Ukraine, 03022 - Kiev/UA
  • 2 Department Of Modifiers Of Antitumor Therapy, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS, 03022 - Kiev/UA
  • 3 University Administration, NMU - National Medical University named after O.O. Bogomolets, 01601 - Kiev/UA
  • 4 Chief Medical Officer Dept, National Cancer Institute of the Ministry of Health of Ukraine, 03022 - Kiev/UA

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 28P

Background

Obesity and related diseases, namely, diabetes and metabolic syndrome, are associated with chronic inflammation and colorectal cancer (CRC). In CRC liver metastases (mCRC) and adjacent liver tissue defects are formed in the mitochondrial electron transport chain that causes mitochondrial dysfunction, activation of redox-molecules (SR, NO) generation sources and MMP-2, -9 activity. Radical oxygen species take a part in the regulation of gelatinases (MMP-2 and -9) and the xanthine/xanthine oxidase reaction is widely used as a source of exogenous ROS in considering of MMPs. The aim of the study was to determine the state of XO, SR and MMPs in liver tissue and CRC liver metastases (MT) and set the clinical significance of obtained results.

Methods

The prospective study on 37 mCRC patients who underwent the liver resection due metastatic disease has been performed. The rate of SR generation of neutrophils and in the tissue samples, the rate of XO and the activity of matrix metalloproteinases in the tissue samples was measured accordingly study design.

Results

The highest level of XO in mCRC patients was detected in metastatic tissue (1.47±0.18 a.u.). The level of XO enzyme in the adjacent tissue (AT) and distant tissue (DT) were 0.38±0.10 a.u. (p<0.05) and 0.19±0.008 a.u. (р<0,05) respectively. A correlation was found between the BMI and amount of XO in DT of the liver r2 = 0,64. The total activity of gelatinases in subgroup of mCRC patients with BMI ≥ 25 was found to be significantly higher than in normal body weight patients withing the DT (1.52; p<0.001), as well as in the AT (1.28 times; p<0.001). High XO levels (HR (95% CI) = 0,002 (2,63 to 15.05) P = 0,002) and SR generation levels (HR (95% CI) = 0,01 (2,4 to 10,37) P = 0,01) in adjusted liver tissue to metastatic lesions had a negative impact on overall overall survival rates.

Conclusions

Xanthine oxidase and superoxide radicals can be a new metastatic disease prognostic factors for colorectal cancer patients, the latter requiring further randomized trials.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.